DFTX Q4 2018 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

Q4 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$1,670

Operating Income

-$126,218

Net Income

-$126,218

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$3M

Total Liabilities

$92,409

Stockholders' Equity

$3M

Cash & Equivalents

$15,645

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,670	-$3,513	+52.5%
Operating Income	-$126,218	-$168,477	+25.1%
Net Income	-$126,218	-$165,383	+23.7%